23andMe Investor Day Presentation Deck

What's Coming: • Next Generation Reports: Polygenic Risk Score reports that incorporate life- style factors to improve risk estimates Genetics-based Primary Care: Delivering personalized, prevention-oriented, genetics-based healthcare at scale by integrating Lemonaid Health's digital health platform with 23andMe's personal genetic services • Advancing Therapeutics Pipeline: Advancing a pipeline of multiple clinical and research stage investigational programs addressing targets validated by human genetics Copyright © 2022 23andMe, Inc. 23andMe® 9

View entire presentation